These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4024268)

  • 1. Activity of the combination of fludalanine and cycloserine against mycobacteria in vitro.
    Dickinson JM; Mitchison DA
    Tubercle; 1985 Jun; 66(2):109-15. PubMed ID: 4024268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of fludalanine combined with pentizidone compared with those of other agents.
    Wise R; Andrews JM
    Antimicrob Agents Chemother; 1984 May; 25(5):612-7. PubMed ID: 6610389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of cycloserine in the treatment of infections caused by nontuberculous mycobacteria viewed from in vitro experiments].
    Tsukamura M
    Kekkaku; 1989 May; 64(5):345-9. PubMed ID: 2507817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of the D-alanine racemase gene confers resistance to D-cycloserine in Mycobacterium smegmatis.
    Cáceres NE; Harris NB; Wellehan JF; Feng Z; Kapur V; Barletta RG
    J Bacteriol; 1997 Aug; 179(16):5046-55. PubMed ID: 9260945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycobacterium smegmatis D-Alanine Racemase Mutants Are Not Dependent on D-Alanine for Growth.
    Chacon O; Feng Z; Harris NB; Cáceres NE; Adams LG; Barletta RG
    Antimicrob Agents Chemother; 2002 Jan; 46(1):47-54. PubMed ID: 11751110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Alanine Racemase Mutations in Mycobacterium tuberculosis d-Cycloserine Resistance.
    Nakatani Y; Opel-Reading HK; Merker M; Machado D; Andres S; Kumar SS; Moradigaravand D; Coll F; Perdigão J; Portugal I; Schön T; Nair D; Devi KRU; Kohl TA; Beckert P; Clark TG; Maphalala G; Khumalo D; Diel R; Klaos K; Aung HL; Cook GM; Parkhill J; Peacock SJ; Swaminathan S; Viveiros M; Niemann S; Krause KL; Köser CU
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High efficacy of clofazimine and its synergistic effect with amikacin against rapidly growing mycobacteria.
    Shen GH; Wu BD; Hu ST; Lin CF; Wu KM; Chen JH
    Int J Antimicrob Agents; 2010 Apr; 35(4):400-4. PubMed ID: 20138481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergic activity of D-cycloserine and beta-chloro-D-alanine against Mycobacterium tuberculosis.
    David S
    J Antimicrob Chemother; 2001 Feb; 47(2):203-6. PubMed ID: 11157908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic and functional analyses of Mycobacterium tuberculosis strains implicate ald in D-cycloserine resistance.
    Desjardins CA; Cohen KA; Munsamy V; Abeel T; Maharaj K; Walker BJ; Shea TP; Almeida DV; Manson AL; Salazar A; Padayatchi N; O'Donnell MR; Mlisana KP; Wortman J; Birren BW; Grosset J; Earl AM; Pym AS
    Nat Genet; 2016 May; 48(5):544-51. PubMed ID: 27064254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic and genetic analyses of D-cycloserine inhibition and resistance in Escherichia coli.
    Curtiss R; Charamella LJ; Berg CM; Harris PE
    J Bacteriol; 1965 Nov; 90(5):1238-50. PubMed ID: 5321479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of NMR metabolomics to analyze the targets of D-cycloserine in mycobacteria: role of D-alanine racemase.
    Halouska S; Chacon O; Fenton RJ; Zinniel DK; Barletta RG; Powers R
    J Proteome Res; 2007 Dec; 6(12):4608-14. PubMed ID: 17979227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of Mycobacterium smegmatis D-alanine:D-alanine ligase and D-alanine racemase in the mechanisms of action of and resistance to the peptidoglycan inhibitor D-cycloserine.
    Feng Z; Barletta RG
    Antimicrob Agents Chemother; 2003 Jan; 47(1):283-91. PubMed ID: 12499203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis underlying Mycobacterium tuberculosis D-cycloserine resistance. Is there a role for ubiquinone and menaquinone metabolic pathways?
    Hong W; Chen L; Xie J
    Expert Opin Ther Targets; 2014 Jun; 18(6):691-701. PubMed ID: 24773568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of mycobacterial D-alanyl-D-alanine synthetase to D-cycloserine.
    David HL; Takayama K; Goldman DS
    Am Rev Respir Dis; 1969 Oct; 100(4):579-81. PubMed ID: 4981706
    [No Abstract]   [Full Text] [Related]  

  • 15. A liquid chromatography-tandem mass spectrometry assay for Marfey's derivatives of L-Ala, D-Ala, and D-Ala-D-Ala: application to the in vivo confirmation of alanine racemase as the target of cycloserine in Escherichia coli.
    Jamindar D; Gutheil WG
    Anal Biochem; 2010 Jan; 396(1):1-7. PubMed ID: 19748470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N(2)-substituted D,L-cycloserine derivatives: synthesis and evaluation as alanine racemase inhibitors.
    Kim MG; Strych U; Krause K; Benedik M; Kohn H
    J Antibiot (Tokyo); 2003 Feb; 56(2):160-8. PubMed ID: 12715876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A side reaction of alanine racemase: transamination of cycloserine.
    Fenn TD; Stamper GF; Morollo AA; Ringe D
    Biochemistry; 2003 May; 42(19):5775-83. PubMed ID: 12741835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multivariate analysis of the activity of rifamycins against rapidly growing Mycobacteria, to define an in vitro screening model for their activity against mycobacterium leprae.
    Pattyn SR; Hébrant F
    Arzneimittelforschung; 1980; 30(12):2099-103. PubMed ID: 7011330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reinterpreting the mechanism of inhibition of Mycobacterium tuberculosis D-alanine:D-alanine ligase by D-cycloserine.
    Prosser GA; de Carvalho LP
    Biochemistry; 2013 Oct; 52(40):7145-9. PubMed ID: 24033232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ANTAGONISM OF D-CYCLOSERINE INHIBITION OF MYCOBACTERIAL GROWTH BY D-ALANINE.
    ZYGMUNT WA
    J Bacteriol; 1963 Jun; 85(6):1217-20. PubMed ID: 14047211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.